Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Is risk of Alzheimer disease a reason to use dietary supplements?

Dwyer J, Donoghue MD.

Am J Clin Nutr. 2010 May;91(5):1155-6. doi: 10.3945/ajcn.2010.29498. Epub 2010 Mar 24. No abstract available.

2.

Forget about ginkgo supplements to aid memory.

[No authors listed]

Mayo Clin Health Lett. 2009 Mar;27(3):4. No abstract available.

PMID:
19402193
3.

Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study.

Ohara T, Ninomiya T, Kubo M, Hirakawa Y, Doi Y, Hata J, Iwaki T, Kanba S, Kiyohara Y.

J Am Geriatr Soc. 2011 Jun;59(6):1074-9. doi: 10.1111/j.1532-5415.2011.03405.x. Epub 2011 Jun 7.

PMID:
21649613
4.

Risk factors of dementia in North India: a case-control study.

Tripathi M, Vibha D, Gupta P, Bhatia R, Srivastava MV, Vivekanandhan S, Bhushan Singh M, Prasad K, Dergalust S, Mendez MF.

Aging Ment Health. 2012;16(2):228-35. doi: 10.1080/13607863.2011.583632. Epub 2011 Jun 30.

PMID:
21714688
5.

ApoE genotype and family history in patients with dementia and cognitively intact spousal controls.

Zintl M, Schmitz G, Hajak G, Klünemann HH.

Am J Alzheimers Dis Other Demen. 2009 Aug-Sep;24(4):349-52. doi: 10.1177/1533317509333040. Epub 2009 Apr 16.

PMID:
19372276
6.

Moderate alcohol consumption, apolipoprotein E, and neuroprotection.

Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemmiale G, Capurso A, Panza F.

Arch Neurol. 2009 Apr;66(4):541-2. doi: 10.1001/archneurol.2009.35. No abstract available.

PMID:
19364947
7.

[Apolipoprotein E typology and dementia].

Reischies FM, Gessner R, Kage A.

Nervenarzt. 1994 Jul;65(7):492-5. Review. German. No abstract available.

PMID:
7800096
8.

Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors.

Messier C, Gagnon M.

Diabetologia. 2009 Dec;52(12):2471-4. doi: 10.1007/s00125-009-1533-2. Epub 2009 Sep 25. No abstract available.

PMID:
19779694
9.

Antioxidants and dementia.

Lethem R, Orrell M.

Lancet. 1997 Apr 26;349(9060):1189-90. No abstract available.

PMID:
9130937
10.

Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.

Chuang WL, Hsieh YC, Wang CY, Kuo HC, Huang CC.

J Geriatr Psychiatry Neurol. 2010 Mar;23(1):42-8. doi: 10.1177/0891988709351804.

PMID:
20145290
11.

Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.

Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM.

Neurology. 2007 Sep 4;69(10):998-1005.

PMID:
17785668
12.

The apolipoprotein-epsilon4 gene: always harmful?

Teasdale TW.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):364-5. doi: 10.1136/jnnp.2007.138081. No abstract available.

PMID:
18344388
13.

Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

Arch Neurol. 2006 Nov;63(11):1586-90.

PMID:
17101827
14.

Distribution of APOE genotypes in a memory clinic cohort.

van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P.

Dement Geriatr Cogn Disord. 2008;25(5):433-8. doi: 10.1159/000124750. Epub 2008 Apr 10.

PMID:
18401171
15.

Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.

van der Flier WM, Staekenborg S, Pijnenburg YA, Gillissen F, Romkes R, Kok A, Bouwman FH, Scheltens P.

Dement Geriatr Cogn Disord. 2007;23(1):42-6. Epub 2006 Oct 31.

PMID:
17077632
16.

How can elderly apolipoprotein E ε4 carriers remain free from dementia?

Ferrari C, Xu WL, Wang HX, Winblad B, Sorbi S, Qiu C, Fratiglioni L.

Neurobiol Aging. 2013 Jan;34(1):13-21. doi: 10.1016/j.neurobiolaging.2012.03.003. Epub 2012 Apr 11.

PMID:
22503000
17.

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.

Borroni B, Grassi M, Costanzi C, Archetti S, Caimi L, Padovani A.

Am J Geriatr Psychiatry. 2006 Dec;14(12):1022-31. Epub 2006 Sep 6.

PMID:
16956959
18.

Accuracy of summary risk score for prediction of Alzheimer disease: better than demographics alone?

Barnes DE, Yaffe K.

Arch Neurol. 2011 Feb;68(2):268; author reply 268-70. doi: 10.1001/archneurol.2011.4. No abstract available.

PMID:
21321000
19.

Association study of the HLA-A2 allele in Italian Alzheimer disease patients.

Guerini FR, Calabrese E, Agliardi C, Zanzottera M, Franceschi M, Grimaldi LM, Nemni R, Ferrante P.

Neurobiol Aging. 2009 Dec;30(12):2082-3. doi: 10.1016/j.neurobiolaging.2008.02.001. Epub 2008 Mar 21.

PMID:
18359130
20.

Vascular risk scores for dementia: age matters.

Reijmer Y, Biessels GJ.

Arch Neurol. 2011 Feb;68(2):267; author reply 268-70. doi: 10.1001/archneurol.2011.2. No abstract available.

PMID:
21320999
Items per page

Supplemental Content

Write to the Help Desk